Literature DB >> 11574191

Macrolide resistance mechanisms in Gram-positive cocci.

J C Pechère1.   

Abstract

Two principal mechanisms of resistance to macrolides have been identified in Gram-positive bacteria. Erythromycin-resistant methylase is encoded by erm genes. Resultant structural changes to rRNA prevent macrolide binding and allow synthesis of bacterial proteins to continue. Presence of the erm gene results in high-level resistance. Modification of the mechanism whereby antibiotics are eliminated from the bacteria also brings about resistance. Bacteria carrying the gene encoding macrolide efflux (i.e. the mefE gene) display relatively low-level resistance. Azithromycin, because of its ability to achieve concentrations at sites of infections, is capable of eradicating mefE-carrying strains. Other resistance mechanisms, involving stimulation of enzymatic degradation, appear not to be clinically significant.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11574191     DOI: 10.1016/s0924-8579(01)00407-1

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  10 in total

1.  Azithromycin versus Penicillin in Acute Group A Streptococcal Tonsillopharyngitis.

Authors:  Itzhak Brook
Journal:  Curr Infect Dis Rep       Date:  2003-06       Impact factor: 3.725

Review 2.  Instructive Advances in Chemical Microbiology Inspired by Nature's Diverse Inventory of Molecules.

Authors:  Ke Liu; Robert W Huigens
Journal:  ACS Infect Dis       Date:  2020-01-06       Impact factor: 5.084

Review 3.  Recent Progress in Natural-Product-Inspired Programs Aimed To Address Antibiotic Resistance and Tolerance.

Authors:  Yasmeen Abouelhassan; Aaron T Garrison; Hongfen Yang; Alejandra Chávez-Riveros; Gena M Burch; Robert W Huigens
Journal:  J Med Chem       Date:  2019-04-18       Impact factor: 7.446

4.  Transcriptional response of Enterococcus faecalis V583 to erythromycin.

Authors:  Agot Aakra; Heidi Vebø; Lars Snipen; Helmut Hirt; Are Aastveit; Vivek Kapur; Gary Dunny; Barbara E Murray; Barbara Murray; Ingolf F Nes
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

5.  Azithromycin effectiveness against intracellular infections of Francisella.

Authors:  Saira Ahmad; Lyman Hunter; Aiping Qin; Barbara J Mann; Monique L van Hoek
Journal:  BMC Microbiol       Date:  2010-04-23       Impact factor: 3.605

6.  Persistence of resistant Staphylococcus epidermidis after single course of clarithromycin.

Authors:  Maria Sjölund; Eva Tano; Martin J Blaser; Dan I Andersson; Lars Engstrand
Journal:  Emerg Infect Dis       Date:  2005-09       Impact factor: 6.883

Review 7.  Resistance of Gram-Positive Bacteria to Current Antibacterial Agents and Overcoming Approaches.

Authors:  Rafik Karaman; Buthaina Jubeh; Zeinab Breijyeh
Journal:  Molecules       Date:  2020-06-23       Impact factor: 4.411

8.  Alterations of gut microbial pathways and virulence factors in hemodialysis patients.

Authors:  Xiaochun Shi; Bei Gao; Anvesha Srivastava; Zahra Izzi; Yoosif Abdalla; Weishou Shen; Dominic Raj
Journal:  Front Cell Infect Microbiol       Date:  2022-08-26       Impact factor: 6.073

Review 9.  Multidrug-Resistant Bacteria: Their Mechanism of Action and Prophylaxis.

Authors:  Alok Bharadwaj; Amisha Rastogi; Swadha Pandey; Saurabh Gupta; Jagdip Singh Sohal
Journal:  Biomed Res Int       Date:  2022-09-05       Impact factor: 3.246

Review 10.  Emerging macrolide resistance in Bordetella pertussis in mainland China: Findings and warning from the global pertussis initiative.

Authors:  Ye Feng; Cheng-Hsun Chiu; Ulrich Heininger; Daniela Flavia Hozbor; Tina Quanbee Tan; Carl-Heinz Wirsing von König
Journal:  Lancet Reg Health West Pac       Date:  2021-02-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.